Improving coping skills for self-management of treatment side effects can reduce antiretroviral medication nonadherence among people living with HIV

Annals of Behavioral Medicine

Volumn 41, Issue 1, 2011, Pages 83-91

  Johnson, Mallory O ^a   Dilworth, Samantha E ^a   Taylor, Jonelle M ^a   Neilands, Torsten B ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Adherence; Antiretroviral therapy; Compliance; RCT; Side effects

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADAPTIVE BEHAVIOR; ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PSYCHOLOGICAL ASPECT; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; SELF CARE; TREATMENT OUTCOME; UNITED STATES;

ADAPTATION, PSYCHOLOGICAL; ADULT; ANTI-HIV AGENTS; FEMALE; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; RANDOM ALLOCATION; SAN FRANCISCO; SELF CARE; TREATMENT OUTCOME;

EID: 79952281647     PISSN: 08836612     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12160-010-9230-4     Document Type: Article

References (47)

1. JA Este T Cihlar 2010 Current status and challenges of antiretroviral research and therapy Antivir Res 85 25 33 1:CAS:528:DC%2BC3cXnvFCmsg%3D%3D 10.1016/j.antiviral.2009.10.007 20018390
2. PE Tarr M Rotger A Telenti 2010 Dyslipidemia in HIV-infected individuals: From pharmacogenetics to pharmacogenomics Pharmacogenomics 11 587 594 1:CAS:528:DC%2BC3cXkvVOitb0%3D 10.2217/pgs.10.35 20350140
3. JA Aberg JE Kaplan H Libman, et al. 2009 Primary care guidelines for the management of persons infected with Human Immunodeficiency Virus: 2009 update by the HIV medicine Association of the Infectious Diseases Society of America Clin Infect Dis 49 651 681 10.1086/605292 19640227
4. Kurtyka D. From terminal disease to chronic illness: HIV infection in 2010. Adv Nurse Pract. 2010; 18: 33-38, 52; quiz 39.
5. P Volberding SG Deeks 2010 Antiretroviral therapy and management of HIV infection Lancet 376 49 62 10.1016/S0140-6736(10)60676-9 20609987
6. L Fogarty D Roter S Larson, et al. 2002 Patient adherence to HIV medication regimens: A review of published and abstract reports [Review] Patient Educ Couns 46 93 108 10.1016/S0738-3991(01)00219-1 11867239 (Pubitemid 34175086)
7. A Ammassari R Murri P Pezzotti, et al. 2001 Self reported symptoms and medication side effects influence adherence to highly active antiretroviral therapy in persons with HIV infection J Acquir Immune Defic Syndr 28 445 449 1:CAS:528:DC%2BD38XltVKkug%3D%3D 11744832 (Pubitemid 34033195)
8. J Shuter 2008 Forgiveness of non-adherence to HIV-1 antiretroviral therapy J Antimicrob Chemother 61 769 773 1:CAS:528:DC%2BD1cXjs1Ojsbo%3D 10.1093/jac/dkn020 18256112 (Pubitemid 351426058)
9. DR Bangsberg 2008 Preventing HIV antiretroviral resistance through better monitoring of treatment adherence J Infect Dis 197 Suppl 3 S272 278 10.1086/533415 18447613 (Pubitemid 351717317)
10. SL Reisner MJ Mimiaga M Skeer, et al. 2009 A review of HIV antiretroviral adherence and intervention studies among HIV-infected youth Top HIV Med 17 14 25 19270345
11. Berg CJ, Michelson SE, Safren SA. Behavioral aspects of HIV care: adherence, depression, substance use, and HIV-transmission behaviors. Infect Dis Clin North Am. 2007; 21: 181-200, x. (Pubitemid 46729632)
12. DR Bangsberg S Perry ED Charlebois, et al. 2001 Non-adherence to highly active antiretroviral therapy predicts progression to AIDS AIDS 15 1181 1183 1:STN:280:DC%2BD3MzltFKhug%3D%3D 10.1097/00002030-200106150-00015 11416722 (Pubitemid 32549871)
13. MO Johnson MA Chesney 2006 The value and challenges of improving adherence to antiretroviral therapy for human immunodeficiency virus Med Care 44 891 892 10.1097/01.mlr.0000242130.51174.9a 17001258 (Pubitemid 44454564)
14. F Clavel AJ Hance 2004 HIV drug resistance N Engl J Med 350 1023 1035 1:CAS:528:DC%2BD2cXhvFGjs7c%3D 14999114 (Pubitemid 38269279)
15. C Protopopescu F Raffi P Roux, et al. 2009 Factors associated with non-adherence to long-term highly active antiretroviral therapy: A 10 year follow-up analysis with correction for the bias induced by missing data J Antimicrob Chemother 64 599 606 1:CAS:528:DC%2BD1MXhtVWju7jI 10.1093/jac/dkp232 19602563
16. JS Gonzalez FJ Penedo MM Llabre, et al. 2007 Physical symptoms, beliefs about medications, negative mood, and long-term HIV medication adherence Ann Behav Med 34 46 55 10.1007/BF02879920 17688396 (Pubitemid 47481224)
17. MO Johnson MA Chesney TB Neilands, et al. 2009 Disparities in reported reasons for not initiating or stopping antiretroviral treatment among a diverse sample of persons living with HIV J Gen Intern Med 24 247 251 10.1007/s11606-008-0854-z 19015925
18. R Horne V Cooper G Gellaitry HL Date M Fisher 2007 Patients' perceptions of highly active antiretroviral therapy in relation to treatment uptake and adherence: The utility of the necessity-concerns framework J Acquir Immune Defic Syndr 45 334 341 17514019 (Pubitemid 47012382)
19. MO Johnson E Charlebois SF Morin, et al. 2005 Perceived adverse effects of antiretroviral therapy J Pain Symptom Manage 29 193 205 10.1016/j. jpainsymman.2004.05.005 15793937 (Pubitemid 40279056)
20. MA Chesney 2000 Factors affecting adherence to antiretroviral therapy Clin Infect Dis 30 Suppl 2 S171 176 10.1086/313849 10860902 (Pubitemid 32268984)
21. MO Johnson T Stallworth TB Neilands 2003 The drugs or the disease? Causal attributions of symptoms held by HIV-positive adults on HAART AIDS Behav 7 109 117 10.1023/A:1023938023005 14586196 (Pubitemid 36781506)
22. MO Johnson S Folkman 2004 Side effect and disease related symptom representations among HIV+ adults on antiretroviral therapy Psychol Health Med 9 139 148 10.1080/13548500410001670672 (Pubitemid 38470561)
23. RH Remien AE Hirky MO Johnson, et al. 2003 Adherence to medication treatment: A qualitative study of facilitators and barriers among a diverse sample of HIV+men and women in four US cities AIDS Behav 7 61 72 10.1023/A:1022513507669 14534391 (Pubitemid 36578367)
24. CF Turner L Ku SM Rogers, et al. 1998 Adolescent sexual behavior, drug use, and violence: Increased reporting with computer survey technology Science 280 867 873 1:CAS:528:DyaK1cXjtFGqtbc%3D 10.1126/science.280.5365.867 9572724 (Pubitemid 28215590)
25. JN Gribble HG Miller SM Rogers CF Turner 1999 Interview mode and measurement of sexual behaviors: Methodological issues J Sex Res 36 16 24 10.1080/00224499909551963 (Pubitemid 29118091)
26. AM Nezu 2004 Problem solving and behavior therapy revisited Behav Ther 35 1 33 10.1016/S0005-7894(04)80002-9 (Pubitemid 38821740)
27. Nezu AM, Nezu CM, Perri MG. Problem-solving therapy for depression: Theory, research, and clinical guidelines: New York, NY, USA, 1989.
28. M Chesney DB Chambers J Taylor L Johnson S Folkman 2003 Coping effectiveness training for men living with HIV: Results from a randomized clinical trial testing a group-based intervention Psychosom Med 65 1038 1046 10.1097/01.PSY.0000097344.78697.ED 14645783 (Pubitemid 38057805)
29. Lazarus RS, Folkman S. Stress, appraisal, and coping. New York: Springer Pub. Co., 1984.
30. Beck A, Steer R, Brown G. Manual for the Beck Depression Inventory-II. San Antonio: Psychological Corporation, 1996.
31. MA Chesney JR Ickovics DB Chambers, et al. 2000 Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG adherence instruments. Patient Care Committee & Adherence Working Group of the Outcomes Committee of the Adult AIDS Clinical Trials Group (AACTG) AIDS Care 12 255 266 1:STN:280:DC%2BD3cvhslKgsA%3D%3D 10.1080/09540120050042891 10928201 (Pubitemid 30426745)
32. Chesney MA, Ickovics J. Adherence to combination therapy in AIDS clinical trials. Annual Meeting of the AIDS Clinical Trials Group. Washington: 1997.
33. MO Johnson SL Catz RH Remien, et al. 2003 Theory guided, empirically supported avenues for intervention on HIV medication nonadherence: Findings from the Healthy Living Project AIDS Patient Care STDs 17 645 656 10.1089/108729103771928708 14746658 (Pubitemid 38031552)
34. JC Walsh AL Pozniak MR Nelson S Mandalia BG Gazzard 2002 Virologic rebound on HAART in the context of low treatment adherence is associated with a low prevalence of antiretroviral drug resistance J Acquir Immune Defic Syndr 30 278 287 1:CAS:528:DC%2BD38XlvFOnsLg%3D 12131564 (Pubitemid 34774075)
35. JC Walsh S Mandalia BG Gazzard 2002 Responses to a 1 month self-report on adherence to antiretroviral therapy are consistent with electronic data and virological treatment outcome AIDS 16 269 277 10.1097/00002030-200201250-00017 11807312 (Pubitemid 34118574)
36. JH Oyugi J Byakika-Tusiime ED Charlebois, et al. 2004 Multiple validated measures of adherence indicate high levels of adherence to generic HIV antiretroviral therapy in a resource-limited setting J Acquir Immune Defic Syndr 36 1100 1102 1:CAS:528:DC%2BD2cXlsFemu78%3D 10.1097/00126334-200408150-00014 15247564 (Pubitemid 38989377)
37. M Lu SA Safren PR Skolnik, et al. 2008 Optimal recall period and response task for self-reported HIV medication adherence AIDS Behav 12 86 94 10.1007/s10461-007-9261-4 17577653 (Pubitemid 351143454)
38. MO Johnson TB Neilands 2007 Coping with HIV treatment side effects: Conceptualization, measurement, and linkages AIDS Behav 11 575 585 10.1007/s10461-007-9229-4 17436074 (Pubitemid 46828778)
39. G Schwarz 1974 Estimating the dimension of a model Ann Stat 6 461 464 10.1214/aos/1176344136
40. JG Morel MC Bokossa NK Neerchal 2003 Small sample correction for the variance of GEE estimators Biom J 45 305 409 10.1002/bimj.200390021 (Pubitemid 36802752)
41. DY Lin LJ Wei Z Ying 2002 Model-checking techniques based on cumulative residuals Biometrics 58 1 12 1:STN:280:DC%2BD387lvVyisA%3D%3D 10.1111/j.0006-341X.2002.00001.x 11890304 (Pubitemid 34194482)
42. MO Johnson ED Charlebois SF Morin, et al. 2007 Effects of a behavioral intervention on antiretroviral medication adherence among people living with HIV: The Healthy Living Project randomized controlled study J Acquir Immune Defic Syndr 46 574 580 10.1097/QAI.0b013e318158a474 18193499 (Pubitemid 350191050)
43. MH Antoni AW Carrico RE Duran, et al. 2006 Randomized clinical trial of cognitive behavioral stress management on human immunodeficiency virus viral load in gay men treated with highly active antiretroviral therapy Psychosom Med 68 143 151 10.1097/01.psy.0000195749.60049.63 16449425 (Pubitemid 43803229)
44. Nezu CM, Nezu AM, Houts PS. Multiple applications of problem-solving principles in clinical practice. In H. Rosen, K. T. Kuehlwein (ed), Cognitive therapies in action: Evolving innovative practice. The Jossey-Bass social and behavioral science series.: Jossey-Bass Inc, Publishers, San Francisco, CA, US, 1993, 353-378.
45. M de Bruin W Viechtbauer H Schaalma, et al. 2010 Standard care impact on effects of highly active antiretroviral therapy adherence interventions: A meta-analysis of randomized controlled trials Arch Intern Med 170 240 250 10.1001/archinternmed.2009.536 20142568
46. JM Simoni AE Kurth CR Pearson, et al. 2006 Self-report measures of antiretroviral therapy adherence: A review with recommendations for HIV research and clinical management AIDS Behav 10 227 245 10.1007/s10461-006-9078-6 16783535
47. DR Bangsberg A Bronstone R Hofmann 2002 A computer-based assessment detects regimen misunderstandings and nonadherence for patients on HIV antiretroviral therapy AIDS Care 14 3 15 1:STN:280:DC%2BD38%2Fnt1altQ%3D%3D 10.1080/09540120220097892 11798401 (Pubitemid 34095162)